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Abstract
Pyrroloindoline alkaloids constitute a large family of natural products that has inspired the
development of an impressive array of new reactions to prepare the key heterocyclic motif. This
synopsis will address catalytic, asymmetric reactions developed to synthesize pyrroloindolines
bearing C3a all-carbon quaternary stereocenters. The methods described herein include both
transition metal-catalyzed and organocatalyzed reactions that have been demonstrated suitable for
the synthesis of the pyrroloindoline framework.
The hexahydropyrrolo[2,3-b]indole, commonly referred to as the pyrroloindoline, is a
common heterocyclic motif that unites several structurally diverse and biosynthetically
distinct families of alkaloids (Figure 1, highlighted in red).1 Alkaloids possessing the
pyrroloindoline framework exhibit a broad array of biological properties, ranging from
antibacterial2 and anticancer activities3 to the inhibition of cholinesterase.4 Many
pyrroloindoline natural products bear C3a all-carbon quaternary stereocenters, and the
synthetic challenge inherent to these structures, combined with their promising medicinal
value, has inspired the development of a variety of inventive methods for the
enantioselective preparation of the core heterocycle.5 Although numerous strategies
involving either chiral auxiliaries or the functionalization of L-tryptophan have been
developed, this synopsis will focus on the catalytic, enantioselective approaches based on
the recent growth of research within this field.
Catalytic, asymmetric reactions to prepare pyrroloindolines can be categorized primarily
into two general approaches: (1) reactions to synthesize 3,3′-disubstituted oxindoles, which
can be elaborated to the corresponding pyrroloindolines,6 or (2) tandem C3-
functionalization/cyclization reactions of 3-substituted indoles. Extensive research has been
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functionalization approach permits direct access to pyrroloindolines, whereas the oxindoles
can serve as intermediates in the synthesis of both pyrroloindoline and oxindole-based
natural products.
Pyrroloindoline Synthesis via 3,3-Disubstituted Oxindoles
3,3′-Disubstituted oxindoles are available by several methods including α-alkylation,
intramolecular cyclization, and intramolecular acyl migration. The first catalytic asymmetric
synthesis of a 3,3′-disubstituted oxindole was developed in 1991 at Hoechst-Roussel
Pharmaceuticals Inc.7 Researchers Wong and Lee discovered that subjection of oxindole 6
to chloroacetonitrile in the presence of cinchoninium bromide catalyst 7 delivered
enantioenriched oxindole 8 (Scheme 1). Further elaboration resulted in a formal total
synthesis of the anticholinesterase natural product physostigmine (1, Figure 1). This
approach built on the pioneering phase transfer catalysis studies of Dolling and coworkers,8
and has been succeeded by several enantioselective organocatalytic α-alkylation reactions of
oxindoles.9 Recently, Luo and coworkers identified a bifunctional tertiary amine thiourea
(10) that catalyzes the conjugate addition of 3-aryl and 3-alkyloxindoles (9) to 2-
chloroacrylonitrile (11).9c Of the asymmetric oxindole alkylation approaches reported to
date, this is the first method that directly installs an appropriate C2-handle for advancement
to diketopiperazine-based alkaloids (e.g. chaetocin A (3), Figure 1).
A second, foundational catalytic asymmetric method to prepare 3,3-disubstituted oxindoles
was the Pd-catalyzed intramolecular Heck reaction reported by Overman and coworkers in
1993 (Scheme 2).10 In a preliminary demonstration of the synthetic utility, physostigmine
(1, Figure 1) was prepared from Z-butenanilide 14 via oxindole carboxaldehyde 15.
Recently, this reaction was applied in more elaborate contexts including the synthesis of the
alkaloids minfiensine (4, Figure 1)11 and polypyrroloindoline quadrigemine C.12 These
transformations are noteworthy examples of asymmetric Heck reactions that generate all-
carbon quaternary centers, and have likely inspired the development of related transition
metal-catalyzed cyclization reactions for the construction of pyrroloindolines.13 For
example, Nakao, Hiyama, Ogoshi and coworkers reported the synthesis of (2-
oxindolyl)acetonitrile derivatives (e.g. 8) by the Ni-catalyzed enantioselective
intramolecular arylcyanation of alkenes (Scheme 2).13c,14 A key finding in this study was
that, in addition to the nickel catalyst, a Lewis acid (AlMe2Cl) was required to promote
oxidative addition of the arylnitrile. Subsequent C-H oxidation furnishes the highly
enantioenriched 3,3′-dialkyl (8) and 3-alkyl-3′-aryloxindoles.
In addition to the Heck-type cyclization reactions described above, transition metal-
catalyzed asymmetric allylic alkylation (AAA) reactions to prepare 3,3-disubstituted
oxindoles have been developed. In 2006, Trost and Zhang reported the Mo-catalyzed AAA
of oxindoles using allyl carbonates as electrophiles,15 and established that these products
could be easily elaborated to the corresponding pyrroloindolines. More recently, the same
group developed a Pd-catalyzed AAA reaction of oxindoles using benzyloxyallene 19 as the
electrophile (Scheme 3).16,17, The advantages of the latter reaction are that (1) it tolerates 3-
indolyloxindole substrate 18, and (2) the benzyloxy substituent in oxindole 21 provides a
useful handle for the synthesis of more oxidized pyrroloindoline frameworks, such as that
found in gliocladin C and related natural products (2, Figure 1).
Most oxindole α-alkylation strategies harness the intrinsic nucleophilicity of enolate
intermediates; however, two recent umpolung approaches employ oxindoles as the
electrophilic component.18 In a 2009 report, Stoltz and coworkers describe a Cu(II)
bisoxazoline (23)-catalyzed stereoablative alkylation of 3-chloro-3-aryloxindoles (22) with
dimethylmalonate, wherein coordination of the malonate to the copper catalyst presumably
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generates a chiral nucleophile (24, Scheme 4).18a The reaction is proposed to occur by
elimination of HCl from 22 to form a transient o-azaxylylene (25); subsequent attack at C3
by 24 delivers the 3,3′-disubstituted oxindole (26). The utility of these products in
pyrroloindoline synthesis was demonstrated for oxindole 26, which following Krapcho
dealkoxycarbonylation, N-methylation, aminolysis, and reductive cyclization afforded 3-
phenylpyrroloindoline 28 in an operationally straightforward manner.
Gong and coworkers have discovered an alternative strategy for the in situ generation of
electrophilic oxindole species that has proven instrumental for bispyrroloindoline
synthesis.18b This reaction involves indole-assisted dehydration, followed by chiral
phosphoric acid (31)-catalyzed addition of enamine 30 to the transient azafulvene (Scheme
5). Mechanistic insight was provided by DFT calculations, which suggest a two-point
binding model for the Brønsted acid that invokes hydrogen bonding of both the enamine and
indole nitrogens (see proposed transition structure 32). The necessary nitrogen functionality
was installed by a Beckmann rearrangement to give 34, which was elaborated in eight
additional steps to (+)-folicanthine (35). Gong and coworkers further applied the asymmetric
methodology to 2-(alkyloxy)acetaldehydes by employing a cinchona alkaloid-derived co-
catalyst and used this chemistry in a synthesis of gliocladin C (2, Figure 1). 19,20
The polypyrroloindoline alkaloids present a particular synthetic challenge due to the
presence of vicinal all-carbon quaternary stereocenters and, therefore, the design of
methodology tailored to these molecules is an important area of research. Shortly following
Gong’s report of the enamine alkylation reaction described above, Kanai, Matsunaga and
coworkers also reported a concise synthesis of (+)-folicanthine (35) (Scheme 6).21 In this
case, installation of the quaternary stereocenters was accomplished by sequential Mn-
catalyzed Michael additions of readily available bisoxindole 36 to nitroethylene. Although
this transformation proved more practical in terms of yield as a two-step process, it is
impressive that the one-flask double Michael addition proceeds with exceptional
enantioselectivity to successfully generate both stereocenters in a single step.
Asymmetric nucleophilic catalysis has also been employed in the synthesis of
enantioenriched pyrroloindolines. In their synthesis of (+)-gliocladine C (45), Overman and
coworkers recognized the utility of the planar-chiral ferrocenyl pyridine (40)-catalyzed
intramolecular acyl O-to-C migration of indolyl carbonates initially disclosed by Fu and
Hills.22,23 Subjection of indolyl trichloro-tert-butylcarbonate 39 to the reported migration
conditions provided oxindole 41 in high yield and ee (Scheme 7). Following further
elaboration, intermolecular aldol reaction of 42 with trioxopiperazine 43 and subsequent
exposure to BF3•OEt2 provided didehydro-pyrroloindoline 44. This cyclization product was
converted to (+)-gliocladine C (45) in 6 steps,24 representing the first total synthesis of an
epidithiodiketopiperazine (ETP) natural product incorporating a β-hydroxy-substituted
stereocenter.
As a complementary approach to asymmetric oxindole syntheses described above, Larionov
and coworkers reported a strategy that invokes instead the intermediacy of an indolyl 1,2-
oxazine (48, Scheme 8).25,26 Similar to the oxindole research, these studies were driven by
both the biological activity of 1,2-oxazine natural products27 and the prospective conversion
to pyrroloindolines. Specifically, Lewis acid-catalyzed [4+2] cycloaddition reactions of 3-
alkylindoles (46) with nitrosoalkenes generated in situ from 2-chlorooximes (47) were found
to afford the desired oxazines. Notably, Gilchrist and Roberts reported a related non-
asymmetric NaHCO3-promoted reaction in 1978,28 but this recent addition to the literature
represents the first catalytic and highly enantioselective cycloaddition of nitrosoalkenes for
any dienophile.29 Beckmann rearrangement of 1,2-oxazine 48 furnished 3-
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allylpyrroloindoline 49, thereby illustrating the utility of this strategy for the synthesis of
both oxazines and pyrroloindolines.
Direct Synthesis of Pyrroloindolines from Indoles and Tryptamines
Over the past decade, direct asymmetric functionalization of 3-substituted indoles has
emerged as a powerful approach for the efficient preparation of pyrroloindolines. In 2004,
MacMillan and coworkers reported a chiral imidazolidinone salt (52)- catalyzed reaction
between acrolein and tryptamine derivatives (50) to generate enantioenriched
pyrroloindolines (51, Scheme 9).30 The proposed mechanism invokes condensation of 52
with acrolein to generate a chiral iminium ion,31 which undergoes a cascade conjugate
addition/cyclization reaction to deliver the pyrroloindoline framework. The appeal of this
reaction is that it harnesses the intrinsic C3-nucleophilicity of indoles and provides direct
access to pyrroloindolines from simple, readily available materials. More recently, the
MacMillan group developed organocatalytic cascade reactions of 2-vinyl-tryptamines (53)
to execute remarkably concise total syntheses of several alkaloids, including minfiensine (4,
Figure 1).32
Since the initial disclosure by MacMillan and coworkers, several other methods for the
direct synthesis of pyrroloindolines from tryptamine derivatives have been reported, and
collectively these reactions provide access to a variety of enantioenriched pyrroloindoline
products. In 2006, Trost and Quancard reported an AAA reaction of tryptamines (56) using
allyl alcohol, activated by a trialkylborane, as the electrophile (Scheme 10).33 Notably, the
enantioselectivity of this AAA reaction is dependent on the choice of both ligand and
borane, with the combination of 9-BBN-C6H13 and anthracene-derived phosphine (S,S)-57
proving optimal.34
Antilla and Zhang recently reported chiral phosphoric acid (65)-catalyzed C–N and C–C
bond formation/cyclization reactions of tryptamine carbamates (59 and 60) (Scheme 11).35a
Preliminary NMR investigations suggest a mechanism involving electrophile activation by a
hydrogen-bonding network. Specifically, it is proposed that coordination of the tryptamine
carbonyl to the catalyst enhances the carbamate acidity and results in hydrogen bonding to
the electrophile (either diethylazodicarboxylate (DEAD, see complex 61) or methyl
vinylketone). This methodology constitutes the first catalytic, asymmetric construction of 3-
aminopyrroloindolines, a motif present in several naturally occurring alkaloids.36
Furthermore, the utility of the C-C bond forming variant has been demonstrated in the
concise total synthesis of (−)-debromoflustramine B (64). Exposure of (1H)-tryptamine 60
to methyl vinyl ketone resulted in substitution at both C3a and N1a to give 63, an
intermediate primed for elaboration to 64. A publication from You and coworkers describing
similar findings with a related phosphoric acid catalyst was reported in close timing with the
Antilla report (not shown).35b
In a recent effort directed toward preparing 3a-arylpyrroloindolines, MacMillan and Zhu
developed a Cu(I)- bisoxazoline (68)-catalyzed intermolecular arylation of indole
carboxamides using aryliodonium salts (67, Scheme 12).37 The proposed mechanism
involves C3-metalation of the indole (66) by a Cu(III)-aryl complex, reductive elimination,
and cyclization of the resultant 3-arylindolenine (71). The excellent enantioinduction likely
results from bidentate substrate coordination (70). This reaction enables the direct
preparation of highly enantioenriched pyrroloindolines (69) and tolerates a variety of
substitution patterns on the arene and indole backbone.
Although the vast majority of direct asymmetric approaches to pyrroloindolines employ
tryptamine derivatives as substrates, Reisman and coworkers pursued an alternative strategy
involving an (R)-BINOL•SnCl4-catalyzed formal (3 + 2) cycloaddition reaction between C3-
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substituted indoles (72) and benzyl-2- trifluoroacetamidoacrylate (73, Scheme 13).38 This
step-wise reaction is proposed to occur by conjugate addition to 73 at C3 of the indole (72),
followed by protonation of the resultant enolate (74) and cyclization to afford the
pyrroloindoline (75). Mechanistic studies suggest that the enantioselectivity originates from
a catalyst-controlled protonation.39 Although the reaction is sensitive to the steric profile of
the indole nucleophile, alkyl substituents are well tolerated, thus providing rapid access to
pyrroloindolines including aza-propellane 78, which contains the core of minfiensine-type
alkaloids (4, Figure 1), and 5-methoxypyrroloindoline 76, a potential precursor to
physostigmine (1, Figure 1). Moreover, this formal cycloaddition reaction offers the only
direct access to the C2 pyrrolidine stereocenter found in diketopiperazine-containing natural
products.
More recently, Spangler and Davies reported a Rh(II)-catalyzed formal (3 + 2) cycloaddition
between C3- substituted indoles and 4-aryl-1-sulfonyl-1,2,3-triazoles to give
enantioenriched tetrahydropyrrolo[2,3-b]indoles (e.g. 81, Scheme 14).40 In this reaction, the
4-aryl-1-sulfonyl-1,2,3-triazole serves as a precursor to a Rh-bound carbenoid. The authors
speculate that the reaction proceeds through cyclopropanation of the indole C2-C3 bond to
give 82, followed by fragmentation of the cyclopropane and cyclization to form the
dihydropyrrole ring. Good yields and excellent enantioselectivities are obtained for a range
of substrates.41
With the exception of the formal cycloaddition reaction developed by Reisman and
coworkers,38 the approaches described in this section all rely on setting the absolute
stereochemistry of the pyrroloindoline through a key, catalytic, C3-functionalization step.
Alternatively, Willis and coworkers pursued a conceptually distinct strategy focused on the
desymmetrization of readily accessible meso-chimonanthine to prepare the related
trispyrroloindoline alkaloid (−)-hodgkinsine B (86, Scheme 15).42 Specifically, a Pd-
catalyzed N-allylation of bispyrroloindoline 84 was achieved using the ligand (R,R)-20, a
chiral phosphine developed by Trost and coworkers (Scheme 3).43 This chemistry finds
precedent in Taguchi and coworkers’ Pd-catalyzed desymmetrization of meso-
cyclohexane-1,2-diamides,44 but the substrate complexity and enantioselectivity are
unparalleled. In combination with the oxindole α-arylation methodology also developed by
Willis and coworkers,45 this allylic substitution-desymmetrization reaction enabled
remarkably rapid access to 86.
The complexity, biological activity, and remarkable variety exhibited by pyrroloindolines
have long established this family of natural products as an important target for total
synthesis. In particular, the past two decades of research resulted in enantioselective,
catalytic strategies for the synthesis of pyrroloindolines bearing C3a all-carbon quaternary
stereocenters. Whereas early synthetic methods focused on the preparation of 3,3′-
disubstituted oxindoles, more recent efforts have started to explore the direct
functionalization of indoles. Despite the breadth of reported transformations, key restrictions
exist regarding functional group incorporation and there is no singular method that is best
for the preparation of the diverse array of structures found in pyrroloindoline alkaloids.
These unmet challenges illustrate the demand for new methodologies and suggest that the
pyrroloindoline scaffold will persist as an inspiration for future research in organic
synthesis.
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Representative pyrroloindoline natural products.
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Organocatalytic α-alkylation of oxindoles.
Conditions: (a) 3.0 equiv 11, 10 mol % 10, 4Å MS, ClCH2CH2Cl, −20 °C, 48 h; (b) NaN3,
DMSO, 30 °C, 24 h; (c) TMSCl, MeOH, rt, 96 h; (d) Red-Al, PhMe, rt to 100 °C, 24 h.
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Cyclization approaches to 3,3′-disubstituted oxindoles.
Conditions: (a) 10 mol % Pd2(dba)3·CHCl3, 23 mol % (S)-BINAP, 5.1 equiv PMP, DMA,
100 °C, 1.5 h. (b) 3 N HCl, 0 to 23 °C (84 % yield, 2 steps). (c) 10 mol % Ni(cod)2, 20 mol
% 17, 40 mol % AlMe2Cl, DME, 100 °C, 10 h (88% yield); (d) 6.0 equiv PhIO, CH2Cl2, rt,
2.5 h (40% yield).
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Pd-catalyzed allylation of oxindoles with benzyloxyallene (19) (Trost and Zhang, 2011).
Conditions: 1.2 equiv 19, 2.5 mol % Pd2(dba)3•CHCl3, 7.5 mol % (R,R)-20, 5 mol % 1-
naphthoic acid, THF, rt, 41 h.
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Cu-catalyzed Umpolung alkylation of 3-halooxindoles (Stoltz and coworkers, 2009).
Conditions: (a) 20 mol % (S)-PhBOX·Cu(II)·2SbF6, 3.0 equiv dimethyl malonate, 2.0 equiv
Et3N, 3 Å MS, CH2Cl2, −20 °C (76% yield). (b) LiCl, H2O, DMSO, 150 °C, 12 h; (c)
tBuOK, MeI, THF, 0 °C, 1 h; (d) AlMe3, MeNH2•HCl, PhMe, 50 °C, 5 d; (e) LAH, THF, 0
°C, 1 h.
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Phosphoric acid-catalyzed Umpolung alkylation of 3-indolyloxindoles en route to (+)-
folicanthine (35) (Gong and coworkers, 2012).
Conditions: (a) 1.5 equiv 30, 10 mol % 31, Na2SO4, CH2Cl2, rt, 12–24 h; (b) aqueous HBr,
EtOH, rt, 8 h; (c) nBu4NHSO4, KOH, THF, 50 °C, 1 h; then MeI, rt, 2 h; (d) NH2OH•HCl,
pyridine, EtOH, rt, 2 d; (e) HgCl2, MeCN, 80 °C, 2 h.
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Mn-catalyzed double Michael reaction en route to (+)-folicanthine (35), (Kanai, Matsunaga
and coworkers, 2012).
Conditions: 1.2 equiv nitroethylene, 18 mol % Mn(4-F-BzO)2/38 (ratio 1:1), PhMe, 5Å MS,
50 °C, 1.5 h; then 2.0 equiv nitroethylene, 1.0 equiv 2,6-di-tert-butylphenol, 50 °C, 12 h.
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First synthesis of a β-hydroxy-ETP natural product (Overman and coworkers, 2011).
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Nitrosoalkene [4+2]/Beckmann rearrangement approach via a 1,2-oxazine intermediate
(Larionov and coworkers, 2012).
Conditions: (a) 10 mol % CuOTf•1/2PhMe, 10 mol % (S)-DM-BINAP, 3.0 equiv Ag2CO3,
3Å MS, CH2Cl2, −15 °C, 48 h; (b) 20 mol % PBr3, C6H5CF3, 50 °C, 16 h (79% yield).
Repka and Reisman Page 17














First direct, enantioselective construction of pyrroloindolines from tryptamines (MacMillan
and coworkers, 2004 and 2009).
Conditions: (a) Acrolein (4.0 equiv), 52 (20 mol %), 85:15 CH2Cl2:H2O, −85 °C, 25 h. (b)
Propynal (3.0 equiv), 55 (15 mol %), Et2O, −40 °C, 24 h; NaBH4, CeCl3, MeOH.
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Pd-catalyzed tandem allylic alkylation/cyclization reaction of tryptamines (Trost and
Quancard, 2006).
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Phosphoric acid (65)-catalyzed preparation of two pyrroloindoline motifs (Antilla and
Zhang, 2012).
Conditions: (a) DEAD (1.5 equiv), 65 (10 mol %), PhMe, 50 °C, 48 h (76% yield). (b)
Methyl vinyl ketone (3.0 equiv), 65 (10 mol%), 4 Å MS, 1:1 PhMe:PhH, −20 °C, 24 h (91%
yield).
Repka and Reisman Page 20














Cu-catalyzed tandem arylation/cyclization reaction of indole carboxamides (MacMillan and
Zhu, 2012).
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(R)-BINOL• SnCl4-catalyzed formal cycloaddition reaction (Reisman and coworkers, 2010).
Conditions: 1.2 equiv SnCl4, 20 mol % (R)-BINOL, CH2Cl2, 23 °C, 4–20 h.
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Rh(II)-catalyzed asymmetric annulation of indoles (Spangler and Davies, 2013).
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Allylic substitution-desymmetrization reaction en route to (−)-hodgkinsine B (86) (Willis
and coworkers, 2011).
Conditions: 1.2 equiv allyl acetate, 2.0 equiv Et3N, 3.8 mol % (R,R)-20, (allylPdCl)2 (1.25
mol %), PhMe, 0 °C, 1.5 h.
Repka and Reisman Page 24
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